EGFR and non-small cell lung carcinoma: In EGFR-mutated non-small cell lung cancer (NSCLC), macrophage-conditioned medium enhances cell migration and resistance to tyrosine kinase inhibitors (TKIs), highlighting the critical role of the tumor microenvironment in cancer progression.